The Yeast Cell Wall Extract market size is estimated at USD 1.25 billion in 2025 and, under the current market forecast model, is projected to reach USD 2.1 billion by 2033, translating to a 7.1% CAGR over 2026-2033. This growth outlook is underpinned by three macro drivers: (1) post-antibiotic era regulations mandating gut-health alternatives in livestock, (2) consumer willingness to pay a premium for immune-support supplements post-pandemic, and (3) biorefinery technology that lifts extract purity above 70% while cutting production cost by ~15%. Competitive intensity is rising as European feed groups and Chinese biotech players backward-integrate into yeast fermentation, tightening raw yeast supply. Meanwhile, regulatory harmonization between EU/US on novel feed ingredients is shortening approval cycles, accelerating industry expansion. Regionally, Asia-Pacific holds the largest revenue share (42%) thanks to massive pork and aquaculture sectors, while North America is the fastest-growing region (>8% CAGR) driven by pet-health and human nutraceutical applications.